The primary goal of pancreatitis management (inflammation of the pancreas) is to arrest parenchymal inflammation, prevent tissue necrosis, suppress systemic inflammatory responses, and manage exocrine or endocrine insufficiency. Depending on whether the condition presents as acute pancreatitis or chronic pancreatitis, care transitions from dynamic inpatient resuscitation to long-term metabolic and structural stabilization within gastroenterology and pancreatology practice.

Initial management centers on fluid resuscitation using balanced crystalloids (Ringer's lactate) titrated to urine output and hemodynamic goals during the first 24 hours. Early oral feeding with a low-fat diet is initiated as soon as abdominal pain subsides and ileus is absent. If oral intake is not tolerated, nasogastric or nasojejunal tube feeding is introduced within 42 to 72 hours. For biliary pancreatitis with acute cholangitis, urgent endoscopic retrograde cholangiopancreatography (ERCP) is performed within 24 hours. If sterile or infected pancreatic necrosis develops, interventions are delayed for at least 4 weeks to allow encapsulation, followed by a step-up approach involving percutaneous drainage, endoscopic transmural drainage, or video-assisted retroperitoneal debridement (VARD). For chronic pancreatitis, management relies on oral pancreatic enzyme replacement capsules taken during meals, tailored non-opioid or neuropathic pain protocols, endoscopic stricture dilation or stenting, and surgical resection or ductal decompression when medical and endoscopic approaches are insufficient.

• Reduction in Mortality and Complications: Goal-directed fluid resuscitation and early enteral feeding significantly reduce systemic complications and infected pancreatic necrosis (American Gastroenterological Association guidelines, Crockett et al., 2018).
• Prevention of Recurrence: Index admission cholecystectomy for biliary pancreatitis reduces 30-day readmissions and recurrent gallstone-related complications by over 70% (NICE NG104 guidelines).
• Restoration of Nutrient Absorption: Pancreatic enzyme replacement therapy improves fat absorption, reverses weight loss, and mitigates micronutrient deficiencies in exocrine pancreatic insufficiency (ESPEN guidelines, Arvanitakis et al., 2020).
• Minimally Invasive Resolution: Step-up endoscopic or percutaneous management of infected necrosis lowers morbidity compared to open surgical debridement (PANTER trial, van Santvoort et al., 2010).

Mild Acute Pancreatitis: Clinical improvement usually occurs within 3 to 7 days with oral refeeding, adequate pain control, and supportive hydration. Patients typically resume daily activities within 1 to 2 weeks.

Severe Acute Pancreatitis: Inpatient hospitalization may extend from several weeks to months, often requiring intensive care monitoring, enteral tube nutrition, and delayed step-up interventions for fluid collections or necrosis. Full recovery may take 3 to 6 months.

Chronic Pancreatitis Management: Requires lifetime outpatient monitoring, enzyme optimization, dietary adjustments, and ongoing pain modulation.

Pancreatitis management addresses both acute and chronic conditions affecting the exocrine and endocrine pancreas, including:

• Acute Pancreatitis: Mild, moderately severe, and severe forms secondary to gallstones, alcohol intake, hypertriglyceridemia, hypercalcemia, drug reactions, or idiopathic causes.
• Chronic Pancreatitis: Long-standing parenchymal fibrosis, ductal strictures, pancreatic ductal calculi, and pseudocysts.
• Pancreatic Insufficiency: Exocrine pancreatic insufficiency (EPI) leading to malabsorption, steatorrhea, and nutrient deficiency, as well as pancreatogenic (Type 3c) diabetes mellitus.
• Complications: Acute fluid collections, pancreatic pseudocysts, walled-off necrosis (WON), splenic vein thrombosis, and infected pancreatic necrosis.

Diagnostic confirmation requires at least two of the following: characteristic abdominal pain, serum lipase or amylase elevated greater than three times normal limits, and cross-sectional imaging evidence. Baseline lab workup includes liver function tests, serum calcium, lipid panels (triglycerides), renal panel, and inflammatory markers. Ultrasound of the right upper quadrant is performed within 24 hours to evaluate for gallstones. Abstinence from alcohol and complete smoking cessation are mandated immediately upon admission.

Complications include infected pancreatic necrosis, persistent systemic organ failure (pulmonary, renal, or cardiovascular), pseudocyst formation, pseudoaneurysms of local arteries, splenic vein thrombosis, exocrine pancreatic insufficiency, and Type 3c diabetes. Interventional complications from ERCP or necrosectomy include hemorrhage, perforation, infection, and bowel fistula formation.

Clinical Patient Journey

Initial Assessment & Diagnosis: Patient presents with epigastric abdominal pain radiating to the back, elevated pancreatic enzymes (lipase or amylase greater than three times the upper limit of normal), and diagnostic cross-sectional imaging (contrast-enhanced computed tomography or magnetic resonance imaging).

Acute Inpatient Care: Administration of targeted intravenous fluid hydration, early enteral nutrition via oral or nasoenteric routes, multimodal analgesia, and close monitoring for organ dysfunction using established scoring systems.

Targeted Interventions: If obstruction, necrosis, or persistent fluid collections develop, step-up therapeutic interventions are deployed, including endoscopic retrograde cholangiopancreatography (ERCP), percutaneous catheter drainage, or minimally invasive necrosectomy.

Outpatient Rehabilitation & Maintenance: Transition to oral pancreatic enzyme replacement therapy (PERT), glycemic control, dietary adaptation, alcohol and tobacco cessation, and long-term surveillance for structural or functional sequelae.